This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Nick Thompson, Managing Director of Fiberight Limited: “Securing this important EU funding enables us to take our promising pilot-scale work over the last five years to the next stage and demonstrate its commercial viability as an economically and environmentally sustainable process.”.
UK biotech company Toraphene says it is preparing to unveil the world’s first truly biodegradable, compostable and commercially viable alternative to plastic packaging.
But Carbios claims its patented process enables a wide variety of used plastics to be recycled back into food-grade PET that might otherwise go to landfill or incineration, potentially providing a continuous, circular system of recycling.
They have run and owned some parts of the value chain and have biotech companies that have patents in different parts of the world that have been majorly funded. Our model was to have a team in contracted IP. Our current R&D team and all of our scientists are South African. AFN: Which markets are you targeting?
Scientific analyses that have been done on the impacts of many biotech crops have identified many benefits , including reducing the use of pesticides and improving the welfare and health of subsistence farmers. So of course they protect these innovations through patents and intellectual property rights.
million) investment in Arkeon from global Israeli specialty minerals company ICL Group , AFN spoke to Gregor Tegel (GT) about Arkeon’s uniqueness in successfully combining ingredients with amino acids as well as its intentions of applying its one-step patented process beyond the food industry. Following the recent $2.9 million (€2.75
In order to reach EU Farm to Fork objectives, we believe it is essential that EU Regulations foster further all innovative solutions, be it biopesticides or pesticides, plant biotech including NGTs or digital and precision agriculture tools so that farmers have access to a full toolbox of effective solutions towards more sustainable farming.”.
We organize all of the trending information in your field so you don't have to. Join 12,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content